Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11017840.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.
Medical subject headings
- Antinematodal Agents
- Hematologic Neoplasms
- Strongyloidiasis
- Thiabendazole